5.12
price down icon3.21%   -0.17
after-market アフターアワーズ: 5.17 0.05 +0.98%
loading
前日終値:
$5.29
開ける:
$5.27
24時間の取引高:
4.55M
Relative Volume:
1.44
時価総額:
$1.01B
収益:
$71.80M
当期純損益:
$-183.59M
株価収益率:
-4.8563
EPS:
-1.0543
ネットキャッシュフロー:
$-186.52M
1週間 パフォーマンス:
+0.59%
1か月 パフォーマンス:
-11.88%
6か月 パフォーマンス:
-63.48%
1年 パフォーマンス:
-49.56%
1日の値動き範囲:
Value
$5.115
$5.32
1週間の範囲:
Value
$5.07
$5.53
52週間の値動き範囲:
Value
$5.01
$21.73

Wave Life Sciences Ltd Stock (WVE) Company Profile

Name
名前
Wave Life Sciences Ltd
Name
セクター
Healthcare (1033)
Name
電話
617-949-2900
Name
住所
7 STRAITS VIEW, SINGAPORE
Name
職員
317
Name
Twitter
@WAVELifeSci
Name
次回の収益日
2026-07-30
Name
最新のSEC提出書
Name
WVE's Discussions on Twitter

Compare WVE vs VRTX, REGN, ARGX, MRNA, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
WVE icon
WVE
Wave Life Sciences Ltd
5.12 1.03B 71.80M -183.59M -186.52M -1.0543
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
547.59 136.93B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
828.50 85.11B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
1,011.11 64.95B 4.16B 1.29B 734.26M 19.58
MRNA icon
MRNA
Moderna Inc
138.89 53.23B 2.23B -3.19B -1.60B -8.1462
RVMD icon
RVMD
Revolution Medicines Inc
211.58 45.38B 742.00K -1.37B -1.07B -7.0731

Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-04-29 再開されました Truist Buy
2026-02-05 開始されました BofA Securities Buy
2025-12-12 繰り返されました Wedbush Outperform
2025-12-09 アップグレード RBC Capital Mkts Sector Perform → Outperform
2025-10-20 開始されました Wells Fargo Overweight
2025-08-04 開始されました Canaccord Genuity Buy
2025-07-28 開始されました Oppenheimer Outperform
2025-07-16 開始されました Citigroup Buy
2025-06-11 再開されました Raymond James Outperform
2025-04-29 開始されました Cantor Fitzgerald Overweight
2025-04-08 開始されました Wedbush Outperform
2025-02-25 開始されました Jefferies Buy
2024-10-16 アップグレード Raymond James Outperform → Strong Buy
2024-09-27 再開されました JP Morgan Overweight
2024-09-19 開始されました B. Riley Securities Buy
2024-09-09 開始されました JP Morgan Overweight
2024-05-15 開始されました Wells Fargo Overweight
2023-12-19 アップグレード Leerink Partners Market Perform → Outperform
2023-07-05 開始されました Raymond James Outperform
2023-05-24 ダウングレード Jefferies Buy → Hold
2020-12-15 再開されました H.C. Wainwright Buy
2020-10-23 開始されました RBC Capital Mkts Sector Perform
2019-12-31 ダウングレード SVB Leerink Outperform → Mkt Perform
2019-11-01 開始されました Guggenheim Buy
2019-07-15 開始されました Cowen Market Perform
2019-04-17 繰り返されました H.C. Wainwright Buy
2018-08-07 開始されました Stifel Buy
2018-07-23 開始されました H.C. Wainwright Buy
2018-03-19 繰り返されました Mizuho Buy
2017-02-15 開始されました H.C. Wainwright Buy
2016-11-10 再開されました Leerink Partners Outperform
2015-12-07 開始されました JMP Securities Mkt Outperform
2015-12-07 開始されました Jefferies Buy
2015-12-07 開始されました Leerink Partners Outperform
2015-12-07 開始されました Sun Trust Rbsn Humphrey Buy
すべてを表示

Wave Life Sciences Ltd (WVE) 最新ニュース

pulisher
Aug 21, 2026

WAVE Life Sciences (NASDAQ:WVE) Downgraded by Zacks Research to "Hold" - MarketBeat

Aug 21, 2026
pulisher
Aug 21, 2026

What Went Wrong For WVE? The Obesity Drug Trial Data That Spooked Investors - Stocktwits

Aug 21, 2026
pulisher
Aug 20, 2026

Wave Life Sciences (WVE) Files To Deregister Its Ordinary Shares - simplywall.st

Aug 20, 2026
pulisher
Aug 20, 2026

WVE Stock Edges Up After Positive Early Data For Rare Disease Drug - Stocktwits

Aug 20, 2026
pulisher
Aug 19, 2026

Wave Life Sciences targets fat loss without sacrificing muscle - Longevity.Technology

Aug 19, 2026
pulisher
Aug 18, 2026

Insiders Sold Wave Life Sciences Prematurely At US$13.64 With Stock Trading Higher - Moomoo

Aug 18, 2026
pulisher
Aug 17, 2026

Wave Life Sciences (WVE) Pulls Back 5.2% to $5.13 as Support Holds at $4.87Thematic ETF Flow - vinanet.vn

Aug 17, 2026
pulisher
Aug 17, 2026

Wave Life Sciences Ltd. SEC Filing (Aug 17, 2026) - Stock Titan

Aug 17, 2026
pulisher
Aug 15, 2026

Precision Trading with Wave Life Sciences Ltd. (WVE) Risk Zones - Stock Traders Daily

Aug 15, 2026
pulisher
Aug 14, 2026

Wave Life Sciences, Inc.: Top Mutual Funds Holders | WVE | US94352A1043 - marketscreener.com

Aug 14, 2026
pulisher
Aug 14, 2026

Wave Life Sciences, Inc.: Target Price Consensus and Analysts Recommendations | WVE | US94352A1043 - marketscreener.com

Aug 14, 2026
pulisher
Aug 14, 2026

Wave Life Sciences, Inc.: Performance & Quotes, WVE Stock Price on Nasdaq Exchange - marketscreener.com

Aug 14, 2026
pulisher
Aug 14, 2026

Wave Life Sciences, Inc.: Fundamental Analysis and Financial Ratings | WVE | US94352A1043 - marketscreener.com

Aug 14, 2026
pulisher
Aug 14, 2026

Wave Life Sciences, Inc.: Financial Data Forecasts Estimates and Expectations | WVE | US94352A1043 - marketscreener.com

Aug 14, 2026
pulisher
Aug 14, 2026

Q1 2025 WAVE Life Sciences Ltd Earnings Call Transcript - GuruFocus

Aug 14, 2026
pulisher
Aug 14, 2026

WAVE Life Sciences Ltd at RBC Capital Markets Global Healthcare Conference Transcript - GuruFocus

Aug 14, 2026
pulisher
Aug 14, 2026

Q2 2026 WAVE Life Sciences Ltd Earnings Call Transcript - GuruFocus

Aug 14, 2026
pulisher
Aug 14, 2026

Wave Life Sciences Ltd.: Revenue and Earnings Analysts Forecasts Revisions | WVE | US94352A1043 - marketscreener.com

Aug 14, 2026
pulisher
Aug 14, 2026

Wave Life Sciences (WVE) Director Adrian Rawcliffe Sells 12,700 Shares, Reducing Stake to Zero - GuruFocus

Aug 14, 2026
pulisher
Aug 13, 2026

WAVE Life Sciences (NASDAQ:WVE) Director Adrian Rawcliffe Sells 12,700 Shares - MarketBeat

Aug 13, 2026
pulisher
Aug 13, 2026

Ken Takanashi Sells 3,864 Shares of WAVE Life Sciences (NASDAQ:WVE) Stock - MarketBeat

Aug 13, 2026
pulisher
Aug 13, 2026

Wave Life Sciences (WVE) director’s 3,864-share tax sale under 10b5-1 plan - Stock Titan

Aug 13, 2026
pulisher
Aug 13, 2026

Wave Life Sciences: A $1 Billion RNA-Medicine Bargain Ripe for Pharma Takeover - Yahoo Finance

Aug 13, 2026
pulisher
Aug 13, 2026

Insider Selling: WAVE Life Sciences (NASDAQ:WVE) Director Sells $42,070.00 in Stock - MarketBeat

Aug 13, 2026
pulisher
Aug 12, 2026

Wave Life Sciences (WVE) Stock Looks Cheap After A 68% Fall But Expensive On Sales - simplywall.st

Aug 12, 2026
pulisher
Aug 12, 2026

Wave Life Sciences Ltd. SEC Filing (Aug 12, 2026) - Stock Titan

Aug 12, 2026
pulisher
Aug 12, 2026

Wave Life Sciences at canaccord growth conference: obesity and RNA bets - Investing.com Canada

Aug 12, 2026
pulisher
Aug 12, 2026

BofA Securities Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $17 - Moomoo

Aug 12, 2026
pulisher
Aug 12, 2026

WAVE Life Sciences (NASDAQ:WVE) Hits New 52-Week LowHere's What Happened - MarketBeat

Aug 12, 2026
pulisher
Aug 12, 2026

Wave Life Sciences: An Fairly Valued RNA Opportunity - Seeking Alpha

Aug 12, 2026
pulisher
Aug 11, 2026

Wave Life Sciences stock hits 52-week low at $5.01 By Investing.com - Investing.com Australia

Aug 11, 2026
pulisher
Aug 11, 2026

RA Capital group discloses 16.8% Wave Life Sciences (WVE) ownership after redomiciliation - Stock Titan

Aug 11, 2026
pulisher
Aug 11, 2026

Wave Life Sciences Ltd. SEC Filing (Aug 11, 2026) - Stock Titan

Aug 11, 2026
pulisher
Aug 11, 2026

Wave Life Sciences stock hits 52-week low at $5.01 - Investing.com

Aug 11, 2026
pulisher
Aug 11, 2026

Wave Life Sciences at Bank of America SMID Cap Virtual Conference: pipeline bets - Investing.com Nigeria

Aug 11, 2026
pulisher
Aug 11, 2026

WAVE Life Sciences (NASDAQ:WVE) Stock Price Down 6.8%Should You Sell? - MarketBeat

Aug 11, 2026
pulisher
Aug 11, 2026

Q2 2025 WAVE Life Sciences Ltd Earnings Call Transcript - GuruFocus

Aug 11, 2026
pulisher
Aug 11, 2026

Wave Life Sciences Inc (FRA:0VS) Stock Earnings Transcripts - GuruFocus

Aug 11, 2026
pulisher
Aug 11, 2026

Wave Life Sciences Ltd. (WVE) Stock Analysis: Exploring A 214% Upside In Biotech's Future - DirectorsTalk Interviews

Aug 11, 2026
pulisher
Aug 11, 2026

WAVE Life Sciences: Target Price Consensus and Analysts Recommendations | WVE | US94352A1043 - marketscreener.com

Aug 11, 2026
pulisher
Aug 11, 2026

WAVE Life Sciences: Fundamental Analysis and Financial Ratings | WVE | US94352A1043 - marketscreener.com

Aug 11, 2026
pulisher
Aug 11, 2026

WAVE Life Sciences: Financial Data Forecasts Estimates and Expectations | WVE | US94352A1043 - marketscreener.com

Aug 11, 2026
pulisher
Aug 10, 2026

Analysts Just Made A Major Revision To Their Wave Life Sciences Ltd. (NASDAQ:WVE) Revenue Forecasts - webull.com

Aug 10, 2026
pulisher
Aug 10, 2026

WAVE Life Sciences (NASDAQ:WVE) Shares Gap UpHere's Why - MarketBeat

Aug 10, 2026
pulisher
Aug 10, 2026

Wave Life Sciences Completes Redomiciliation to Delaware - marketscreener.com

Aug 10, 2026
pulisher
Aug 10, 2026

Wave Life Sciences completes redomiciliation to Delaware By Investing.com - Investing.com Australia

Aug 10, 2026
pulisher
Aug 10, 2026

Wave Life Sciences Completes Redomiciliation From Singapore to Delaware - citybiz

Aug 10, 2026
pulisher
Aug 10, 2026

Wave Life Sciences completes redomiciliation to Delaware - Investing.com

Aug 10, 2026
pulisher
Aug 10, 2026

Wave Life Sciences Announces Completion of Redomiciliation to Delaware Corporation - Quiver Quantitative

Aug 10, 2026
pulisher
Aug 10, 2026

Wave Life Sciences Announces Completion of Redomiciliation to Delaware - The Manila Times

Aug 10, 2026
pulisher
Aug 10, 2026

Wave Life Sciences Announces Completion of Redomiciliation to Delaware | Associated Press | syndication news - Enidnews.com

Aug 10, 2026

Wave Life Sciences Ltd (WVE) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Wave Life Sciences Ltd (WVE) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Wagner Heidi L
Director
Aug 11 '26
Sale
6.01
7,000
42,070
44,930
Rawcliffe Adrian
Director
Aug 12 '26
Sale
5.29
12,700
67,183
0
TAKANASHI KEN
Director
Aug 11 '26
Sale
6.01
3,864
23,223
20,079
Tan Aik Na
Director
Aug 11 '26
Sale
6.01
432
2,596
24,968
$123.98
price up icon 0.00%
$61.33
price up icon 0.03%
$112.82
price down icon 3.22%
$236.01
price down icon 0.09%
ONC ONC
$371.98
price down icon 0.66%
$211.58
price up icon 1.01%
大文字化:     |  ボリューム (24 時間):